{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:03:02Z","timestamp":1785333782460,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000373"],"award-info":[{"award-number":["82000373"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270526"],"award-info":[{"award-number":["82270526"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The National Key Research and Development Program of Shaanxi Province","award":["2023-YBSF-105"],"award-info":[{"award-number":["2023-YBSF-105"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s11010-024-04955-9","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T10:01:45Z","timestamp":1714644105000},"page":"1817-1831","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Follistatin-like protein 1 attenuates doxorubicin-induced cardiomyopathy by inhibiting MsrB2-mediated mitophagy"],"prefix":"10.1007","volume":"479","author":[{"given":"Linhe","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengen","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayou","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"key":"4955_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jconrel.2020.08.033","volume":"328","author":"M Mohammadi","year":"2020","unstructured":"Mohammadi M, Arabi L, Alibolandi M (2020) Doxorubicin-loaded composite nanogels for cancer treatment. J Control Release 328:171\u2013191. https:\/\/doi.org\/10.1016\/j.jconrel.2020.08.033","journal-title":"J Control Release"},{"key":"4955_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41419-021-03614-x","volume":"12","author":"E Christidi","year":"2021","unstructured":"Christidi E, Brunham LR (2021) Regulated cell death pathways in doxorubicin-induced cardiotoxicity. Cell Death Dis 12:339. https:\/\/doi.org\/10.1038\/s41419-021-03614-x","journal-title":"Cell Death Dis"},{"key":"4955_CR3","doi-asserted-by":"publisher","first-page":"102089","DOI":"10.1016\/j.redox.2021.102089","volume":"46","author":"D Li","year":"2021","unstructured":"Li D, Yang Y, Wang S, He X, Liu M, Bai B, Tian C, Sun R, Yu T, Chu X (2021) Role of acetylation in doxorubicin-induced cardiotoxicity. Redox Biol 46:102089. https:\/\/doi.org\/10.1016\/j.redox.2021.102089","journal-title":"Redox Biol"},{"key":"4955_CR4","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","volume":"126","author":"KB Wallace","year":"2020","unstructured":"Wallace KB, Sardao VA, Oliveira PJ (2020) Mitochondrial determinants of Doxorubicin-Induced Cardiomyopathy. Circ Res 126:926\u2013941. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.314681","journal-title":"Circ Res"},{"key":"4955_CR5","doi-asserted-by":"publisher","first-page":"e2117396119","DOI":"10.1073\/pnas.2117396119","volume":"119","author":"N Ta","year":"2022","unstructured":"Ta N, Qu C, Wu H, Zhang D, Sun T, Li Y, Wang J, Wang X, Tang T, Chen Q, Liu L (2022) Mitochondrial outer membrane protein FUNDC2 promotes ferroptosis and contributes to doxorubicin-induced cardiomyopathy. Proc Natl Acad Sci U S A 119:e2117396119. https:\/\/doi.org\/10.1073\/pnas.2117396119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4955_CR6","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1080\/15548627.2021.2007027","volume":"18","author":"J Yao","year":"2022","unstructured":"Yao J, Wang J, Xu Y, Guo Q, Sun Y, Liu J, Li S, Guo Y, Wei L (2022) CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma. Autophagy 18:1879\u20131897. https:\/\/doi.org\/10.1080\/15548627.2021.2007027","journal-title":"Autophagy"},{"key":"4955_CR7","doi-asserted-by":"publisher","first-page":"102185","DOI":"10.1016\/j.redox.2021.102185","volume":"48","author":"H He","year":"2021","unstructured":"He H, Wang L, Qiao Y, Yang B, Yin D, He M (2021) Epigallocatechin-3-gallate pretreatment alleviates doxorubicin-induced ferroptosis and cardiotoxicity by upregulating AMPKalpha2 and activating adaptive autophagy. Redox Biol 48:102185. https:\/\/doi.org\/10.1016\/j.redox.2021.102185","journal-title":"Redox Biol"},{"key":"4955_CR8","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/CIRCRESAHA.119.315432","volume":"125","author":"Y Cao","year":"2019","unstructured":"Cao Y, Xu C, Ye J, He Q, Zhang X, Jia S, Qiao X, Zhang C, Liu R, Weng L, Liu Y, Liu L, Zheng M (2019) Miro2 regulates inter-mitochondrial communication in the heart and protects against TAC-Induced Cardiac Dysfunction. Circ Res 125:728\u2013743. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315432","journal-title":"Circ Res"},{"key":"4955_CR9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/s41467-019-08924-5","volume":"10","author":"CW Hsieh","year":"2019","unstructured":"Hsieh CW, Yang WY (2019) Omegasome-proximal PtdIns(4,5)P2 couples F-actin mediated mitoaggregate disassembly with autophagosome formation during mitophagy. Nat Commun 10:969. https:\/\/doi.org\/10.1038\/s41467-019-08924-5","journal-title":"Nat Commun"},{"key":"4955_CR10","doi-asserted-by":"publisher","first-page":"154130","DOI":"10.1016\/j.phymed.2022.154130","volume":"101","author":"B Chen","year":"2022","unstructured":"Chen B, Zhang JP (2022) Bcl-xL is required for the protective effects of low-dose berberine against doxorubicin-induced cardiotoxicity through blocking apoptosis and activating mitophagy-mediated ROS elimination. Phytomedicine 101:154130. https:\/\/doi.org\/10.1016\/j.phymed.2022.154130","journal-title":"Phytomedicine"},{"key":"4955_CR11","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1161\/CIRCRESAHA.117.312317","volume":"122","author":"B Wang","year":"2018","unstructured":"Wang B, Nie J, Wu L, Hu Y, Wen Z, Dong L, Zou MH, Chen C, Wang DW (2018) AMPKalpha2 protects against the development of Heart failure by enhancing Mitophagy via PINK1 phosphorylation. Circ Res 122:712\u2013729. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.312317","journal-title":"Circ Res"},{"key":"4955_CR12","doi-asserted-by":"publisher","first-page":"e10409","DOI":"10.15252\/emmm.201910409","volume":"11","author":"SH Lee","year":"2019","unstructured":"Lee SH, Lee S, Du J, Jain K, Ding M, Kadado AJ, Atteya G, Jaji Z, Tyagi T, Kim WH, Herzog RI, Patel A, Ionescu CN, Martin KA, Hwa J (2019) Mitochondrial MsrB2 serves as a switch and transducer for mitophagy. EMBO Mol Med 11:e10409. https:\/\/doi.org\/10.15252\/emmm.201910409","journal-title":"EMBO Mol Med"},{"key":"4955_CR13","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1136\/gutjnl-2021-325150","volume":"71","author":"J Rao","year":"2022","unstructured":"Rao J, Wang H, Ni M, Wang Z, Wang Z, Wei S, Liu M, Wang P, Qiu J, Zhang L, Wu C, Shen H, Wang X, Cheng F, Lu L (2022) FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2. Gut 71:2539\u20132550. https:\/\/doi.org\/10.1136\/gutjnl-2021-325150","journal-title":"Gut"},{"key":"4955_CR14","doi-asserted-by":"publisher","first-page":"757068","DOI":"10.3389\/fcell.2021.757068","volume":"9","author":"L Lu","year":"2021","unstructured":"Lu L, Ma J, Liu Y, Shao Y, Xiong X, Duan W, Gao E, Yang Q, Chen S, Yang J, Ren J, Zheng Q, Liu J (2021) FSTL1-USP10-Notch1 signaling Axis protects against Cardiac Dysfunction through Inhibition of Myocardial Fibrosis in Diabetic mice. Front Cell Dev Biol 9:757068. https:\/\/doi.org\/10.3389\/fcell.2021.757068","journal-title":"Front Cell Dev Biol"},{"key":"4955_CR15","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/eji.201344063","volume":"44","author":"Y Chaly","year":"2014","unstructured":"Chaly Y, Fu Y, Marinov A, Hostager B, Yan W, Campfield B, Kellum JA, Bushnell D, Wang Y, Vockley J, Hirsch R (2014) Follistatin-like protein 1 enhances NLRP3 inflammasome-mediated IL-1beta secretion from monocytes and macrophages. Eur J Immunol 44:1467\u20131479. https:\/\/doi.org\/10.1002\/eji.201344063","journal-title":"Eur J Immunol"},{"key":"4955_CR16","doi-asserted-by":"publisher","first-page":"3598715","DOI":"10.1155\/2020\/3598715","volume":"2020","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Sun J, Zhang W, Peng M, Chen J, Zheng L, Zhang X, Yang H, Liu Y (2020) Follistatin-Like 1 protects against Doxorubicin-Induced Cardiomyopathy through Upregulation of Nrf2. Oxid Med Cell Longev 2020:3598715. https:\/\/doi.org\/10.1155\/2020\/3598715","journal-title":"Oxid Med Cell Longev"},{"key":"4955_CR17","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1002\/jsfa.9757","volume":"99","author":"Z Wang","year":"2019","unstructured":"Wang Z, Liang M, Li H, Cai L, He H, Wu Q, Yang L (2019) l-Methionine activates Nrf2-ARE pathway to induce endogenous antioxidant activity for depressing ROS-derived oxidative stress in growing rats. J Sci Food Agric 99:4849\u20134862. https:\/\/doi.org\/10.1002\/jsfa.9757","journal-title":"J Sci Food Agric"},{"key":"4955_CR18","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1002\/ctm2.166","volume":"10","author":"L Lu","year":"2020","unstructured":"Lu L, Ma J, Tang J, Liu Y, Zheng Q, Chen S, Gao E, Ren J, Yang L, Yang J (2020) Irisin attenuates myocardial ischemia\/reperfusion-induced cardiac dysfunction by regulating ER-mitochondria interaction through a mitochondrial ubiquitin ligase-dependent mechanism. Clin Transl Med 10:e166. https:\/\/doi.org\/10.1002\/ctm2.166","journal-title":"Clin Transl Med"},{"key":"4955_CR19","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1161\/CIRCRESAHA.115.307604","volume":"118","author":"HY Fu","year":"2016","unstructured":"Fu HY, Sanada S, Matsuzaki T, Liao Y, Okuda K, Yamato M, Tsuchida S, Araki R, Asano Y, Asanuma H, Asakura M, French BA, Sakata Y, Kitakaze M, Minamino T (2016) Chemical Endoplasmic Reticulum Chaperone alleviates Doxorubicin-Induced Cardiac Dysfunction. Circ Res 118:798\u2013809. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.307604","journal-title":"Circ Res"},{"key":"4955_CR20","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.bbadis.2015.12.014","volume":"1862","author":"W Ge","year":"2016","unstructured":"Ge W, Yuan M, Ceylan AF, Wang X, Ren J (2016) Mitochondrial aldehyde dehydrogenase protects against doxorubicin cardiotoxicity through a transient receptor potential channel vanilloid 1-mediated mechanism. Biochim Biophys Acta 1862:622\u2013634. https:\/\/doi.org\/10.1016\/j.bbadis.2015.12.014","journal-title":"Biochim Biophys Acta"},{"key":"4955_CR21","doi-asserted-by":"publisher","first-page":"101215","DOI":"10.1016\/j.redox.2019.101215","volume":"24","author":"N Li","year":"2019","unstructured":"Li N, Zhou H, Wu H, Wu Q, Duan M, Deng W, Tang Q (2019) STING-IRF3 contributes to lipopolysaccharide-induced cardiac dysfunction, inflammation, apoptosis and pyroptosis by activating NLRP3. Redox Biol 24:101215. https:\/\/doi.org\/10.1016\/j.redox.2019.101215","journal-title":"Redox Biol"},{"key":"4955_CR22","doi-asserted-by":"publisher","first-page":"113199","DOI":"10.1016\/j.biopha.2022.113199","volume":"152","author":"X Xiong","year":"2022","unstructured":"Xiong X, Lu L, Wang Z, Ma J, Shao Y, Liu Y, Zhai M, Jin P, Yang J, Zheng Q, Liu J, Yang L (2022) Irisin attenuates sepsis-induced cardiac dysfunction by attenuating inflammation-induced pyroptosis through a mitochondrial ubiquitin ligase-dependent mechanism. Biomed Pharmacother 152:113199. https:\/\/doi.org\/10.1016\/j.biopha.2022.113199","journal-title":"Biomed Pharmacother"},{"key":"4955_CR23","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.bbadis.2016.12.021","volume":"1863","author":"Y Ma","year":"2017","unstructured":"Ma Y, Yang L, Ma J, Lu L, Wang X, Ren J, Yang J (2017) Rutin attenuates doxorubicin-induced cardiotoxicity via regulating autophagy and apoptosis. Biochim Biophys Acta Mol Basis Dis 1863:1904\u20131911. https:\/\/doi.org\/10.1016\/j.bbadis.2016.12.021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4955_CR24","doi-asserted-by":"publisher","unstructured":"Lu L, Ma J, Sun M, Wang X, Gao E, Lu L, Ren J, Yang L, Yang J (2020) Melatonin ameliorates MI-Induced Cardiac Remodeling and apoptosis through a JNK\/p53-Dependent mechanism in diabetes Mellitus. Oxid Med Cell Longev 2020(1535201). https:\/\/doi.org\/10.1155\/2020\/1535201","DOI":"10.1155\/2020\/1535201"},{"key":"4955_CR25","doi-asserted-by":"publisher","first-page":"102310","DOI":"10.1016\/j.redox.2022.102310","volume":"52","author":"AJ Wang","year":"2022","unstructured":"Wang AJ, Tang Y, Zhang J, Wang BJ, Xiao M, Lu G, Li J, Liu Q, Guo Y, Gu J (2022) Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2. Redox Biol 52:102310. https:\/\/doi.org\/10.1016\/j.redox.2022.102310","journal-title":"Redox Biol"},{"key":"4955_CR26","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41418-019-0372-z","volume":"27","author":"X Zhang","year":"2020","unstructured":"Zhang X, Hu C, Kong CY, Song P, Wu HM, Xu SC, Yuan YP, Deng W, Ma ZG, Tang QZ (2020) FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death Differ 27:540\u2013555. https:\/\/doi.org\/10.1038\/s41418-019-0372-z","journal-title":"Cell Death Differ"},{"key":"4955_CR27","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ymthe.2021.07.004","volume":"30","author":"X Wu","year":"2022","unstructured":"Wu X, Wang L, Wang K, Li J, Chen R, Wu X, Ni G, Liu C, Das S, Sluijter JPG, Li X, Xiao J (2022) ADAR2 increases in exercised heart and protects against myocardial infarction and doxorubicin-induced cardiotoxicity. Mol Ther 30:400\u2013414. https:\/\/doi.org\/10.1016\/j.ymthe.2021.07.004","journal-title":"Mol Ther"},{"key":"4955_CR28","doi-asserted-by":"publisher","first-page":"e004486","DOI":"10.1161\/CIRCHEARTFAILURE.117.004486","volume":"11","author":"M Seki","year":"2018","unstructured":"Seki M, Powers JC, Maruyama S, Zuriaga MA, Wu CL, Kurishima C, Kim L, Johnson J, Poidomani A, Wang T, Munoz E, Rajan S, Park JY, Walsh K, Recchia FA (2018) Acute and Chronic increases of circulating FSTL1 normalize energy substrate metabolism in Pacing-Induced Heart failure. Circ Heart Fail 11:e004486. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004486","journal-title":"Circ Heart Fail"},{"key":"4955_CR29","doi-asserted-by":"publisher","first-page":"32424","DOI":"10.1038\/srep32424","volume":"6","author":"Y Xi","year":"2016","unstructured":"Xi Y, Gong DW, Tian Z (2016) FSTL1 as a potential mediator of Exercise-Induced Cardioprotection in Post-myocardial Infarction rats. Sci Rep 6:32424. https:\/\/doi.org\/10.1038\/srep32424","journal-title":"Sci Rep"},{"key":"4955_CR30","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1172\/JCI120849","volume":"128","author":"B Zhou","year":"2018","unstructured":"Zhou B, Tian R (2018) Mitochondrial dysfunction in pathophysiology of heart failure. J Clin Invest 128:3716\u20133726. https:\/\/doi.org\/10.1172\/JCI120849","journal-title":"J Clin Invest"},{"key":"4955_CR31","doi-asserted-by":"publisher","unstructured":"Schirone L, D\u2019Ambrosio L, Forte M, Genovese R, Schiavon S, Spinosa G, Iacovone G, Valenti V, Frati G, Sciarretta S (2022) Mitochondria and Doxorubicin-Induced Cardiomyopathy: a Complex Interplay. Cells 11. https:\/\/doi.org\/10.3390\/cells11132000","DOI":"10.3390\/cells11132000"},{"key":"4955_CR32","doi-asserted-by":"publisher","unstructured":"Tadokoro T, Ikeda M, Ide T, Deguchi H, Ikeda S, Okabe K, Ishikita A, Matsushima S, Koumura T, Yamada KI, Imai H, Tsutsui H (2020) Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight 5. https:\/\/doi.org\/10.1172\/jci.insight.132747","DOI":"10.1172\/jci.insight.132747"},{"key":"4955_CR33","doi-asserted-by":"publisher","first-page":"111708","DOI":"10.1016\/j.biopha.2021.111708","volume":"139","author":"PS Rawat","year":"2021","unstructured":"Rawat PS, Jaiswal A, Khurana A, Bhatti JS, Navik U (2021) Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management. Biomed Pharmacother 139:111708. https:\/\/doi.org\/10.1016\/j.biopha.2021.111708","journal-title":"Biomed Pharmacother"},{"key":"4955_CR34","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.bbadis.2019.05.007","volume":"1865","author":"M Yang","year":"2019","unstructured":"Yang M, Linn BS, Zhang Y, Ren J (2019) Mitophagy and mitochondrial integrity in cardiac ischemia-reperfusion injury. Biochim Biophys Acta Mol Basis Dis 1865:2293\u20132302. https:\/\/doi.org\/10.1016\/j.bbadis.2019.05.007","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4955_CR35","doi-asserted-by":"publisher","first-page":"11096","DOI":"10.1096\/fj.201802663R","volume":"33","author":"MP Catanzaro","year":"2019","unstructured":"Catanzaro MP, Weiner A, Kaminaris A, Li C, Cai F, Zhao F, Kobayashi S, Kobayashi T, Huang Y, Sesaki H, Liang Q (2019) Doxorubicin-induced cardiomyocyte death is mediated by unchecked mitochondrial fission and mitophagy. FASEB J 33:11096\u201311108. https:\/\/doi.org\/10.1096\/fj.201802663R","journal-title":"FASEB J"},{"key":"4955_CR36","doi-asserted-by":"publisher","first-page":"104846","DOI":"10.1016\/j.phrs.2020.104846","volume":"157","author":"X Liang","year":"2020","unstructured":"Liang X, Wang S, Wang L, Ceylan AF, Ren J, Zhang Y (2020) Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission. Pharmacol Res 157:104846. https:\/\/doi.org\/10.1016\/j.phrs.2020.104846","journal-title":"Pharmacol Res"},{"key":"4955_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.yjmcc.2019.06.005","volume":"133","author":"P Wang","year":"2019","unstructured":"Wang P, Wang L, Lu J, Hu Y, Wang Q, Li Z, Cai S, Liang L, Guo K, Xie J, Wang J, Lan R, Shen J, Liu P (2019) SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function. J Mol Cell Cardiol 133:125\u2013137. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.06.005","journal-title":"J Mol Cell Cardiol"},{"key":"4955_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijcard.2019.07.074","volume":"296","author":"X Liu","year":"2019","unstructured":"Liu X, Zhang S, An L, Wu J, Hu X, Lai S, Mazhar H, Zou Y, He L, Zhu H (2019) Loss of Rubicon ameliorates doxorubicin-induced cardiotoxicity through enhancement of mitochondrial quality. Int J Cardiol 296:129\u2013135. https:\/\/doi.org\/10.1016\/j.ijcard.2019.07.074","journal-title":"Int J Cardiol"},{"key":"4955_CR39","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1073\/pnas.0911187107","volume":"107","author":"C Vives-Bauza","year":"2010","unstructured":"Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RL, Kim J, May J, Tocilescu MA, Liu W, Ko HS, Magrane J, Moore DJ, Dawson VL, Grailhe R, Dawson TM, Li C, Tieu K, Przedborski S (2010) PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A 107:378\u2013383. https:\/\/doi.org\/10.1073\/pnas.0911187107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4955_CR40","doi-asserted-by":"publisher","unstructured":"Goldenthal MJ (2016) Mitochondrial involvement in myocyte death and heart failure. Heart Fail Rev 21. https:\/\/doi.org\/10.1007\/s10741-016-9531-1. :137\u2009\u2013\u200955","DOI":"10.1007\/s10741-016-9531-1"},{"key":"4955_CR41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.expneurol.2019.05.006","volume":"318","author":"XJ Xiang","year":"2019","unstructured":"Xiang XJ, Song L, Deng XJ, Tang Y, Min Z, Luo B, Wen QX, Li KY, Chen J, Ma YL, Zhu BL, Yan Z, Chen GJ (2019) Mitochondrial methionine sulfoxide reductase B2 links oxidative stress to Alzheimer\u2019s disease-like pathology. Exp Neurol 318:145\u2013156. https:\/\/doi.org\/10.1016\/j.expneurol.2019.05.006","journal-title":"Exp Neurol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-04955-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-024-04955-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-04955-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T07:30:07Z","timestamp":1721201407000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-024-04955-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["4955"],"URL":"https:\/\/doi.org\/10.1007\/s11010-024-04955-9","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]},"assertion":[{"value":"8 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures and protocols were reviewed and approved by the Air Force Medical University Institutional Committee on Animal Care and this study was performed according to the National Institutes of Health Guidelines on the Use of Laboratory Animals (National Institutes of Health Publication No. 8523, revised 1996). Approval letter No: 20220431.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}